Mabalirajan Ulaganathan

Title: Mabalirajan Ulaganathan: Innovator in Asthma Treatment

Introduction

Mabalirajan Ulaganathan is a notable inventor based in New Delhi, India. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel compounds for the treatment of asthma. His work has led to the filing of multiple patents, showcasing his innovative approach to addressing respiratory diseases.

Latest Patents

Mabalirajan Ulaganathan holds 2 patents that focus on innovative treatments for asthma. His latest patents include "Triazine-aryl-bis-indoles and process for preparation thereof," which describes a novel heterocyclic compound useful for asthma treatment. This invention not only presents the compound but also demonstrates the pathway by which it inhibits asthma. Additionally, he has developed a "Method for treatment of bronchial asthma," which involves administering carbazole derivatives to patients suffering from asthma and chronic obstructive pulmonary disease (COPD). This method includes the use of pharmaceutically acceptable excipients to enhance efficacy.

Career Highlights

Mabalirajan Ulaganathan is affiliated with the Council of Scientific & Industrial Research, where he conducts research aimed at improving therapeutic options for respiratory conditions. His dedication to innovation in this field has positioned him as a key figure in pharmaceutical research.

Collaborations

Mabalirajan has collaborated with notable colleagues, including Vasanta Madhava Sharma Gangavaram and Jhillu Singh Yadav. These collaborations have further enriched his research and contributed to the advancement of asthma treatment methodologies.

Conclusion

Mabalirajan Ulaganathan's work exemplifies the impact of innovative research in the treatment of asthma. His patents reflect a commitment to improving patient outcomes through scientific discovery. His contributions are vital in the ongoing battle against respiratory diseases.